Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of BAY 1817080 versus placebo and elagolix in women with symptomatic endometriosis
2020-003131-16Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eliapixant in endometriosis (5 arms), sponsored by Bayer. Primary endpoint: Absolute change in mean worst endometriosis-associated pelvic pain from baseline to end of intervention. Started Oct 2020; status: completed.
02
Drugs
eliapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2020-003131-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003131-16.